© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
JPMorgan Healthcare Leaders ETF (JDOC) stock declined over -1.01%, trading at $60.81 on NASDAQ, down from the previous close of $61.43. The stock opened at $60.81, fluctuating between $60.76 and $60.81 in the recent session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 10, 2026 | 60.81 | 60.81 | 60.81 | 60.81 | 111 |
| Sep 09, 2026 | 61.23 | 61.23 | 61.23 | 61.23 | 23 |
| Sep 08, 2026 | 61.76 | 61.76 | 61.43 | 61.58 | 411 |
| Sep 04, 2026 | 62.88 | 62.88 | 62.88 | 62.88 | 94 |
| Sep 03, 2026 | 63.62 | 63.62 | 63.62 | 63.62 | 15 |
| Sep 02, 2026 | 63.15 | 63.36 | 63.15 | 63.36 | 300 |
| Sep 01, 2026 | 63.00 | 63.00 | 62.56 | 62.56 | 273 |
| Aug 31, 2026 | 62.60 | 62.60 | 62.60 | 62.60 | 71 |
| Aug 28, 2026 | 62.99 | 62.99 | 62.74 | 62.77 | 1.28K |
| Aug 27, 2026 | 63.36 | 63.36 | 63.36 | 63.36 | 35 |
| Aug 26, 2026 | 64.07 | 64.07 | 64.05 | 64.05 | 391 |
| Aug 25, 2026 | 64.43 | 64.69 | 64.43 | 64.66 | 693 |
| Aug 24, 2026 | 63.85 | 64.17 | 63.85 | 64.17 | 1.01K |
| Aug 21, 2026 | 64.25 | 64.25 | 64.25 | 64.25 | 70 |
| Aug 20, 2026 | 63.66 | 63.66 | 63.66 | 63.66 | 296 |
| Aug 19, 2026 | 63.69 | 64.56 | 63.69 | 64.56 | 229 |
| Aug 18, 2026 | 62.85 | 62.85 | 62.85 | 62.85 | 53 |
| Aug 17, 2026 | 62.04 | 62.12 | 62.04 | 62.12 | 267 |
| Aug 14, 2026 | 61.83 | 61.83 | 61.83 | 61.83 | 68 |
| Aug 13, 2026 | 62.09 | 62.09 | 62.09 | 62.09 | 190 |
New York, NY 10179
United States
https://am.jpmorgan.com/us/en/asset-management/adv/products/jpmorgan-healthcare-leaders-etf-etf-shares-46654q765800 480 4111The fund primarily allocates its capital to the common stock of companies within the broad healthcare sector, specifically targeting businesses engaged in pharmaceuticals, biotechnology, healthcare services, health technology, medical technology, and life sciences. The adviser seeks out industry leaders in these areas whose potential for future growth, both in scale and longevity, is believed to be underestimated by the market. Under typical market conditions, a minimum of 80% of the fund's assets will be invested in the equity securities of such healthcare-related enterprises.
| Employees | 0 |
| Beta | 0.45 |
| Sales or Revenue | N/A |
| 5Y Sales Change% | N/A |
| Fiscal Year Ends | N/A |
| Sector | Financial Services |
| Industry | Asset Management |